BioStock: Focus on market establisment for Chordate

As Chordate Medical reports its second-quarter results, it is no surprise that the spotlight is on the recently signed agreement with Neurolite. The company has already secured an initial order and remains focused on expanding its presence in Switzerland and other key target markets.
– Interest among specialists and neurologists is growing, and Ozilia is a unique alternative that an increasing number of migraine care providers are considering, says CEO Anders Weilandt.

Read the full article at biostock.se:

https://www.biostock.se/en/2024/09/focus-on-market-establisment-for-chordate/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se